Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Novocure Ltd (NVCR)  
$22.32 0.83 (3.59%) as of 4:30 Tue 5/28


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 101,800,000
Market Cap: 2.27(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.13 - $82.51
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NovoCure is an oncology company with a platform technology called Tumor Treating Fields. Co. is focusing on commercial adoption of Optune and NovoTTF-100L. Optune is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in combination with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Co. also has approval to market Optune for the treatment of GBM in the European Union, Japan and certain other countries. NovoTTF-100L is approved by the FDA to treat malignant pleural mesothelioma in combination with chemotherapies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 5,843 10,224 13,200 434,026
Total Sell Value $93,610 $164,332 $235,406 $41,239,900
Total People Sold 2 2 4 10
Total Sell Transactions 4 6 11 52
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 906
  Page 15 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Doyle William F Executive Chairman   •       •      –    2020-05-07 4 S $64.74 $2,006,518 D/D (30,993) 654,426 -77%     
   Doyle William F Executive Chairman   •       •      –    2020-05-07 4 OE $64.77 $3,806,403 D/D 58,768 685,419     -
   Doyle William F Executive Chairman   •       •      –    2020-05-06 4 OE $64.15 $3,769,967 D/D 58,768 626,651     -
   Doyle William F Executive Chairman   •       •      –    2020-05-06 4 S $64.27 $1,920,452 D/D (29,881) 567,883 -75%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-05-05 4 AS $62.20 $71,468 D/D (1,149) 100,693 70%     
   Doyle William F Executive Chairman   •       •      –    2020-05-05 4 S $62.47 $1,891,718 D/D (30,283) 597,764 -70%     
   Doyle William F Executive Chairman   •       •      –    2020-05-05 4 OE $61.40 $3,608,355 D/D 58,768 628,047     -
   Doyle William F Executive Chairman   •       •      –    2020-05-04 4 OE $60.48 $3,554,289 D/D 58,768 569,279     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-05-04 4 S $60.08 $71,134 D/D (1,184) 101,842 -59%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-05-01 4 OE $65.80 $153,511 D/D 2,333 103,026     -
   Weinberg Uri Chief Science OfficerOfficer   •       –      –    2020-04-30 3 IO $0.00 $0 D/D 0 21,454 19%     
   Weinberg Uri Chief Science OfficerOfficer   •       –      –    2020-04-30 3 IO $0.00 $0 D/D 0 2,773 19%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-04-14 4 AS $70.99 $1,953,970 D/D (27,519) 220,867 12%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-04-14 4 OE $7.15 $255,577 D/D 35,745 256,612     -
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-04-13 4 AS $69.01 $2,147,594 D/D (30,981) 248,386 12%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-04-13 4 OE $7.15 $162,698 D/D 22,755 243,622     -
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-03-06 4 S $69.53 $158,120 D/D (2,274) 220,867 15%     
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-03-06 4 S $69.53 $217,155 D/D (3,123) 140,386 15%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-03-06 4 AS $64.27 $410,622 D/D (6,151) 100,693 -15%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-03-06 4 OE $7.48 $130,900 D/D 17,500 103,938     -
   Longsworth Todd Christopher General Counsel   •       –      –    2020-03-06 4 S $69.53 $173,765 D/D (2,499) 86,753 15%     
   Doyle William F Executive Chairman   •       •      –    2020-03-06 4 S $69.53 $300,387 D/D (4,320) 510,511 15%     
   Benaim Ely Chief Medical Officer   •       –      –    2020-03-03 4 A $0.00 $0 D/D 14,415 30,032     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-03-03 4 A $0.00 $0 D/D 21,623 89,344     -
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-03-03 4 A $0.00 $0 D/D 24,025 143,509     -
  906 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us